US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Elevation Oncology Inc (ELEV)
Elevation Oncology Inc (ELEV) ニュース

ELEV

Elevation Oncology (ELEV)

Elevation Oncology Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ELEV

1 2 3 4 5 6 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/02	20 : 30	PR Newswire (US)	Elevation Oncology Reports First Quarter 2024 Financial Results and Highlights Recent Business Achievements	NASDAQ:ELEV	Elevation Oncology Inc
2024/04/09	05 : 30	PR Newswire (US)	Elevation Oncology Presents Preclinical Proof-of-Concept Data for HER3-ADC Program at AACR Annual Meeting 2024	NASDAQ:ELEV	Elevation Oncology Inc
2024/03/06	22 : 14	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:ELEV	Elevation Oncology Inc
2024/03/06	21 : 45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELEV	Elevation Oncology Inc
2024/03/06	21 : 30	PR Newswire (US)	Elevation Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Achievements	NASDAQ:ELEV	Elevation Oncology Inc
2024/03/06	21 : 00	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:ELEV	Elevation Oncology Inc
2024/03/06	06 : 50	PR Newswire (US)	Elevation Oncology to Present Preclinical Proof-of-Concept Data for HER3-ADC Program at the American Association for Cancer Research (AACR) Annual Meeting 2024	NASDAQ:ELEV	Elevation Oncology Inc
2024/03/05	06 : 40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELEV	Elevation Oncology Inc
2024/03/05	06 : 21	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ELEV	Elevation Oncology Inc
2024/03/04	21 : 30	PR Newswire (US)	Elevation Oncology Appoints Experienced Clinical Development Leaders Julie Cherrington, Ph.D. and Alan Sandler, M.D. to Board of Directors	NASDAQ:ELEV	Elevation Oncology Inc
2024/02/28	21 : 30	PR Newswire (US)	Elevation Oncology to Participate in Upcoming Investor Conferences	NASDAQ:ELEV	Elevation Oncology Inc
2024/02/22	21 : 30	PR Newswire (US)	Elevation Oncology Expands Ongoing Phase 1 Clinical Trial of EO-3021 Globally, Dosing First Patient in Japan	NASDAQ:ELEV	Elevation Oncology Inc
2024/02/21	07 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELEV	Elevation Oncology Inc
2024/02/21	06 : 57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELEV	Elevation Oncology Inc
2024/02/21	06 : 52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELEV	Elevation Oncology Inc
2024/02/15	06 : 45	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ELEV	Elevation Oncology Inc
2024/01/24	06 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELEV	Elevation Oncology Inc
2024/01/23	06 : 57	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:ELEV	Elevation Oncology Inc
2024/01/23	06 : 35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELEV	Elevation Oncology Inc
2024/01/23	06 : 24	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ELEV	Elevation Oncology Inc
2024/01/22	21 : 45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELEV	Elevation Oncology Inc
2024/01/22	21 : 30	PR Newswire (US)	Elevation Oncology Announces Appointment of Darcy Mootz, Ph.D., to its Board of Directors	NASDAQ:ELEV	Elevation Oncology Inc
2024/01/10	06 : 24	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ELEV	Elevation Oncology Inc
2024/01/05	21 : 40	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELEV	Elevation Oncology Inc
2024/01/05	21 : 30	PR Newswire (US)	Elevation Oncology Announces Program Updates and Upcoming 2024 Milestones	NASDAQ:ELEV	Elevation Oncology Inc
2023/11/22	21 : 30	PR Newswire (US)	Elevation Oncology to Present at the Piper Sandler 35th Annual Healthcare Conference	NASDAQ:ELEV	Elevation Oncology Inc
2023/11/02	20 : 45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELEV	Elevation Oncology Inc
2023/11/02	20 : 30	PR Newswire (US)	Elevation Oncology Reports Third Quarter 2023 Financial Results and Highlights Recent Business Achievements	NASDAQ:ELEV	Elevation Oncology Inc
2023/11/02	20 : 00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ELEV	Elevation Oncology Inc
2023/09/23	05 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELEV	Elevation Oncology Inc

Showing the most relevant articles for your search:NASDAQ:ELEV

1 2 3 4 5 6 次へ >>

Energy Select Sector SPDR

Bank of America

Verizon Communications

US Dollar vs Euro

BNP Paribas (QX)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約